Medical Marijuana for Pain

Toronto Poly Clinic provides an Evidence-Based Medical Cannabis Opioid Reduction Program: MCORP. Proper use of Medical Cannabis based on the current evidence and guides along with proper opioid tapering schedule based on the Canadian National Opioid Guidelines and Mental Wellness support.

Medical Marijuana Research for conditions not responding to other treatments:

Toronto Poly Clinic is now accepting candidates for participation in an Ethics Board approved long term observational study on effects and side effects of Medical Marijuana in Chronic Non Cancer population. Toronto Poly Clinic follows guides provided by the College of Family Physicians of Canada and the College of Physicians and surgeons of Ontario for use of Medical Marijuana in design and conduction of this study. Patients can contact their family doctors to be referred for consideration of participating in this study.

Subject Selection and Withdrawal criterias:

Inclusion Criteria:

Age 25 – 90
Both men and women
Diagnosis of CNCP longer than the past six months
CNCP conditions include:
Neuropathic Pain: Diabetic, Post traumatic, Post Herpetic, central, wide spread neuropathic pain
Multiple sclerosis (MS) muscle spasms and/or pain
Chronic abdominal pain of Inflammatory Bowel Disease (Crohn’s disease and Ulcerative colitis)
Chronic pelvic pain, Pelvic Inflammatory Disease (PID), advanced endometriosis
Complex regional pain syndrome
Phantom limb pain
Chronic Post-surgical pain
Chronic intractable headaches
Chronic musculoskeletal (MSK) pain due to recurrent seizure disorder
Failed back syndrome with neuropathic or mixed pain non responsive to other treatments

Exclusion Criteria:

Cardiovascular disease (angina, peripheral vascular disease, cerebrovascular disease, arrhythmias), respiratory or oral disease or any other serious systemic disorders
Cancer pain
Pregnancy, planning to become pregnant or breast feeding
History of schizophrenia, other psychosis, other significant psychiatric disorder or unstable mood disorder
Younger than 25 years old (Relative exclusion: Exceptional consideration can be made for extreme cases of younger than 25 years old with the absolute cut off at 18 years old)
History of any legal issues related to Cannabis, alcohol or other controlled substances
Previous history of any adverse or serious adverse events due to use of cannabis

Subject withdrawal criteria:

Participants are free to withdraw from the study anytime they wish. Besides, if any patient display side effects from MM, this patient will be excluded from the study.
Dr. Kevin ROD the principal investigator of this study has extensive experience in conducting clinical trials on new medications. For example Toronto Poly Clinic conducted five of the multi-center clinical trials of the newest opioid medication: Tepentadol and was the largest Canadian recruiter center for these studies. Dr. ROD has also a long history of performing medical investigations on the quality assurance of physician prescribing practices for the College of Physicians and Surgeons of Ontario. As a result he is well familiar with the standards of practice in prescribing controlled substances. Dr. ROD of is hoping by conducting ethical high standard medical research on Medical Cannabis we can have a better understanding about effects and side effects of this substance in the hopes of finding better ways to help our patients. Participation is free of charge to patients.

Please note:

Toronto Poly Clinic does not engage in the unethical practice of accepting referral fees from Licensed Producers for referring patients or prescribing medical marijuana to patients by way of providing medical documents or any other means.